Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

ATNM

Actinium Pharmaceuticals Inc

May 29 • 04:00PM ET

1.26

+0.11 9.57 %

Healthcare • Biotechnology • USA • Nano • AMEX

Peers: ATOS GRCE INMB LTRN OTLK QNTM RNXT VERU XLO TLPH

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.75	Insider Own	3.10%	Shs Outstand	31.37M	Perf Week	6.78%
Market Cap	39.53M	Forward P/E	-	EPS next Y	-0.79	Insider Trans	0.00%	Shs Float	30.40M	Perf Month	7.69%
Enterprise Value	-1.08M	PEG	-	EPS next Q	-0.21	Inst Own	19.35%	Short Float	3.44%	Perf Quarter	6.78%
Income	-23.47M	P/S	439.22	EPS this Y	24.08%	Inst Trans	-0.93%	Short Ratio	6.12	Perf Half Y	-10.00%
Sales	0.09M	P/B	17.16	EPS next Y	4.13%	ROA	-41.15%	Short Interest	1.05M	Perf YTD	-7.35%
Book/sh	0.07	P/C	0.94	EPS next 5Y	23.57%	ROE	-167.66%	52W High	1.95 -35.23%	Perf Year	-20.25%
Cash/sh	1.34	P/FCF	-	EPS past 3/5Y	7.39% 9.91%	ROIC	-759.83%	52W Low	0.95 32.36%	Perf 3Y	-84.62%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-54.09% -	Gross Margin	-828.89%	Volatility	4.52% 5.60%	Perf 5Y	-84.56%
Dividend TTM	-	EV/Sales	-12.00	EPS Y/Y TTM	48.96%	Oper. Margin	-28346.67%	ATR (14)	0.07	Perf 10Y	-97.72%
Dividend Ex-Date	-	Quick Ratio	5.89	Sales Y/Y TTM	11.11%	Profit Margin	-26078.89%	RSI (14)	54.98	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	5.89	EPS Q/Q	65.39%	SMA20	3.19%	Beta	-0.09	Target Price	5.75
Payout	-	Debt/Eq	0.66	Sales Q/Q	-	SMA50	6.34%	Rel Volume	0.88	Prev Close	1.15
Employees	25	LT Debt/Eq	0.34	Earnings	May 11	SMA200	-7.39%	Avg Volume	171.07K	Price	1.26
IPO	Jun 02, 2011	Option/Short	Yes / Yes	EPS/Sales Surpr.	4.44% -	Trades		Volume	150,985	Change	9.57%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)